Specific serotonergic denervation affects tau pathology and cognition without altering senile plaques deposition in APP/PS1 mice

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Ramos Rodriguez, Juan Jose ^a   Molina Gil, Sara ^a   Rey Brea, Raquel ^a,b   Berrocoso, Esther ^a,b   Garcia Alloza, Monica ^a  

^a UNIVERSITY OF CÁDIZ   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

5,7 DIHYDROXITRIPTAMINE; AMYLOID BETA PROTEIN; NEUROTOXIN; TAU PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DENERVATION; MORRIS WATER MAZE TEST; MOUSE; NERVE DEGENERATION; NEUROTRANSMISSION; NONHUMAN; PROTEIN PHOSPHORYLATION; RAPHE NUCLEUS; SENILE PLAQUE; SEROTONERGIC DENERVATION; SEROTONINERGIC SYSTEM; TAUOPATHY;

AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BEHAVIOR, ANIMAL; CHOLINE O-ACETYLTRANSFERASE; COGNITION; DENERVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; MICE; PHOSPHORYLATION; PRESENILIN-1; SEROTONIN; TAU PROTEINS; TAUOPATHIES; TRYPTOPHAN HYDROXYLASE;

EID: 84896725927     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079947     Document Type: Article

References (58)

1. Walsh DM, Selkoe DJ (2004) Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron 44: 181-193. (Pubitemid 39348839)
2. Jin M, Shepardson N, Yang T, Chen G, Walsh D, et al. (2011) Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration. Proc Natl Acad Sci U S A 108: 5819-5824.
3. Meyer-Luehmann M, Spires-Jones TL, Prada C, Garcia-Alloza M, de Calignon A, et al. (2008) Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease. Nature 451: 720-724. (Pubitemid 351220570)
4. Menuet C, Borghgraef P, Matarazzo V, Gielis L, Lajard AM, et al. (2011) Raphe tauopathy alters serotonin metabolism and breathing activity in terminal Tau.P301L mice: possible implications for tauopathies and Alzheimer's disease. Respir Physiol Neurobiol 178: 290-303.
5. de Calignon A, Polydoro M, Suarez-Calvet M, William C, Adamowicz DH, et al. (2012) Propagation of tau pathology in a model of early Alzheimer's disease. Neuron 73: 685-697.
6. Ramos-Rodriguez JJ, Pacheco-Herrero M, Thyssen D, Murillo-Carretero MI, Berrocoso E, et al. (2013) Rapid beta-Amyloid Deposition and Cognitive Impairment After Cholinergic Denervation in APP/PS1 Mice. J Neuropathol Exp Neurol 72: 272-285.
7. Heneka MT, Ramanathan M, Jacobs AH, Dumitrescu-Ozimek L, Bilkei-Gorzo A, et al. (2006) Locus ceruleus degeneration promotes Alzheimer pathogenesis in amyloid precursor protein 23 transgenic mice. J Neurosci 26: 1343-1354. (Pubitemid 43237005)
8. Cowen P, Sherwood AC (2013) The role of serotonin in cognitive function: evidence from recent studies and implications for understanding depression. J Psychopharmacol.
9. Simic G, Stanic G, Mladinov M, Jovanov-Milosevic N, Kostovic I, et al. (2009) Does Alzheimer's disease begin in the brainstem? Neuropathol Appl Neurobiol 35: 532-554.
10. Devanand DP, Sano M, Tang MX, Taylor S, Gurland BJ, et al. (1996) Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community. Arch Gen Psychiatry 53: 175-182. (Pubitemid 26049393)
11. Jost BC, Grossberg GT (1996) The evolution of psychiatric symptoms in Alzheimer's disease: a natural history study. J Am Geriatr Soc 44: 1078-1081. (Pubitemid 26304552)
12. Xu Y, Yan J, Zhou P, Li J, Gao H, et al. (2012) Neurotransmitter receptors and cognitive dysfunction in Alzheimer's disease and Parkinson's disease. Prog Neurobiol 97: 1-13.
13. Grinberg LT, Rub U, Ferretti RE, Nitrini R, Farfel JM, et al. (2009) The dorsal raphe nucleus shows phospho-tau neurofibrillary changes before the transentorhinal region in Alzheimer's disease. A precocious onset? Neuropathol Appl Neurobiol 35: 406-416.
14. Garcia-Alloza M, Robbins EM, Zhang-Nunes SX, Purcell SM, Betensky RA, et al. (2006) Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease. Neurobiol Dis 24: 516-524. (Pubitemid 44716680)
15. Jankowsky JL, Fadale DJ, Anderson J, Xu GM, Gonzales V, et al. (2004) Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum Mol Genet 13: 159-170. (Pubitemid 38111354)
16. Jankowsky JL, Melnikova T, Fadale DJ, Xu GM, Slunt HH, et al. (2005) Environmental enrichment mitigates cognitive deficits in a mouse model of Alzheimer's disease. J Neurosci 25: 5217-5224. (Pubitemid 40726973)
17. Perez SE, Dar S, Ikonomovic MD, DeKosky ST, Mufson EJ (2007) Cholinergic forebrain degeneration in the APPswe/PS1DeltaE9 transgenic mouse. Neurobiol Dis 28: 3-15. (Pubitemid 47429971)
18. de Almeida RM, Nikulina EM, Faccidomo S, Fish EW, Miczek KA (2001) Zolmitriptan - a 5-HT1B/D agonist, alcohol, and aggression in mice. Psychopharmacology (Berl) 157: 131-141. (Pubitemid 32802124)
19. Paulus EV, Mintz EM (2012) Developmental disruption of the serotonin system alters circadian rhythms. Physiol Behav 105: 257-263.
20. Yalcin I, Coubard S, Bodard S, Chalon S, Belzung C (2008) Effects of 5,7-dihydroxytryptamine lesion of the dorsal raphe nucleus on the antidepressant-like action of tramadol in the unpredictable chronic mild stress in mice. Psychopharmacology (Berl) 200: 497-507.
21. Heal DJ, Philpot J, Molyneux SG, Metz A (1985) Intracerebroventricular administration of 5,7-dihydroxytryptamine to mice increases both head-twitch response and the number of cortical 5-HT2 receptors. Neuropharmacology 24: 1201-1205. (Pubitemid 16182645)
22. Hohmann CF, Richardson C, Pitts E, Berger-Sweeney J (2000) Neonatal 5,7-DHT lesions cause sex-specific changes in mouse cortical morphogenesis. Neural Plast 7: 213-232. (Pubitemid 32725512)
23. Jha S, Rajendran R, Davda J, Vaidya VA (2006) Selective serotonin depletion does not regulate hippocampal neurogenesis in the adult rat brain: differential effects of p-chlorophenylalanine and 5,7-dihydroxytryptamine. Brain Res 1075: 48-59.
24. Franklin KBJ, Paxinos G (1997) The Mouse Brain in Stereotaxic Coordinates. Academic Press United States.
25. Yen YC, Anderzhanova E, Bunck M, Schuller J, Landgraf R, et al. (2013) Cosegregation of hyperactivity, active coping styles, and cognitive dysfunction in mice selectively bred for low levels of anxiety. Front Behav Neurosci 7: 103.
26. Morris R (1984) Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 11: 47-60.
27. Wiesehan K, Buder K, Linke RP, Patt S, Stoldt M, et al. (2003) Selection of D-amino-acid peptides that bind to Alzheimer's disease amyloid peptide abeta1-42 by mirror image phage display. Chembiochem 4: 748-753. (Pubitemid 37010600)
28. Polydoro M, Acker CM, Duff K, Castillo PE, Davies P (2009) Age-dependent impairment of cognitive and synaptic function in the htau mouse model of tau pathology. J Neurosci 29: 10741-10749.
29. Chen CP, Eastwood SL, Hope T, McDonald B, Francis PT, et al. (2000) Immunocytochemical study of the dorsal and median raphe nuclei in patients with Alzheimer's disease prospectively assessed for behavioural changes. Neuropathol Appl Neurobiol 26: 347-355. (Pubitemid 30609430)
30. Trillo L, Das D, Hsieh W, Medina B, Moghadam S, et al. (2013) Ascending monoaminergic systems alterations in Alzheimer's disease. Translating basic science into clinical care. Neurosci Biobehav Rev 37: 1363-1379.
31. Garcia-Alloza M, Hirst WD, Chen CP, Lasheras B, Francis PT, et al. (2004) Differential involvement of 5-HT(1B/1D) and 5-HT6 receptors in cognitive and non-cognitive symptoms in Alzheimer's disease. Neuropsychopharmacology 29: 410-416. (Pubitemid 38175158)
32. Pum ME, Huston JP, Muller CP (2009) The role of cortical serotonin in anxiety and locomotor activity in Wistar rats. Behav Neurosci 123: 449-454.
33. Lieben CK, Steinbusch HW, Blokland A (2006) 5,7-DHT lesion of the dorsal raphe nuclei impairs object recognition but not affective behavior and corticosterone response to stressor in the rat. Behav Brain Res 168: 197-207. (Pubitemid 43201936)
34. Hohmann CF, Walker EM, Boylan CB, Blue ME (2007) Neonatal serotonin depletion alters behavioral responses to spatial change and novelty. Brain Res 1139: 163-177.
35. Nelson RL, Guo Z, Halagappa VM, Pearson M, Gray AJ, et al. (2007) Prophylactic treatment with paroxetine ameliorates behavioral deficits and retards the development of amyloid and tau pathologies in 36TgAD mice. Exp Neurol 205: 166-176. (Pubitemid 46617502)
36. Buhot MC, Martin S, Segu L (2000) Role of serotonin in memory impairment. Ann Med 32: 210-221. (Pubitemid 30237566)
37. Piechal A, Blecharz-Klin K, Wyszogrodzka E, Kolomanska P, Rok-Bujko P, et al. (2012) Neonatal serotonin (5-HT) depletion does not affect spatial learning and memory in rats. Pharmacol Rep 64: 266-274.
38. Gutierrez-Guzman BE, Hernandez-Perez JJ, Lopez-Vazquez MA, Fregozo CS, Guevara MA, et al. (2012) Serotonin depletion of supramammillary/posterior hypothalamus nuclei produces place learning deficiencies and alters the concomitant hippocampal theta activity in rats. Eur J Pharmacol 682: 99-109.
39. Lehmann O, Jeltsch H, Lazarus C, Tritschler L, Bertrand F, et al. (2002) Combined 192 IgG-saporin and 5,7-dihydroxytryptamine lesions in the male rat brain: a neurochemical and behavioral study. Pharmacol Biochem Behav 72: 899-912. (Pubitemid 34621317)
40. Lehmann O, Jeltsch H, Lehnardt O, Pain L, Lazarus C, et al. (2000) Combined lesions of cholinergic and serotonergic neurons in the rat brain using 192 IgG-saporin and 5,7-dihydroxytryptamine: neurochemical and behavioural characterization. Eur J Neurosci 12: 67-79. (Pubitemid 30068412)
41. Murtha SJ, Pappas BA (1994) Neurochemical, histopathological and mnemonic effects of combined lesions of the medial septal and serotonin afferents to the hippocampus. Brain Res 651: 16-26. (Pubitemid 24222846)
42. Rodriguez JJ, Noristani HN, Verkhratsky A (2012) The serotonergic system in ageing and Alzheimer's disease. Prog Neurobiol 99: 15-41.
43. Jeltsch-David H, Koenig J, Cassel JC (2008) Modulation of cholinergic functions by serotonin and possible implications in memory: general data and focus on 5-HT(1A) receptors of the medial septum. Behav Brain Res 195: 86-97.
44. Diez-Ariza M, Garcia-Alloza M, Lasheras B, Del Rio J, Ramirez MJ (2002) GABA(A) receptor antagonists enhance cortical acetylcholine release induced by 5-HT(3) receptor blockade in freely moving rats. Brain Res 956: 81-85. (Pubitemid 35335559)
45. Gil-Bea FJ, Dominguez J, Garcia-Alloza M, Marcos B, Lasheras B, et al. (2004) Facilitation of cholinergic transmission by combined treatment of ondansetron with flumazenil after cortical cholinergic deafferentation. Neuropharmacology 47: 225-232. (Pubitemid 38824646)
46. Shen F, Smith JA, Chang R, Bourdet DL, Tsuruda PR, et al. (2011) 5-HT(4) receptor agonist mediated enhancement of cognitive function in vivo and amyloid precursor protein processing in vitro: A pharmacodynamic and pharmacokinetic assessment. Neuropharmacology 61: 69-79.
47. Kalinin S, Gavrilyuk V, Polak PE, Vasser R, Zhao J, et al. (2007) Noradrenaline deficiency in brain increases beta-amyloid plaque burden in an animal model of Alzheimer's disease. Neurobiol Aging 28: 1206-1214. (Pubitemid 46810064)
48. Garcia-Alloza M, Gregory J, Kuchibhotla KV, Fine S, Wei Y, et al. (2011) Cerebrovascular lesions induce transient beta-amyloid deposition. Brain 134: 3697-3707.
49. Harkany T, Dijkstra IM, Oosterink BJ, Horvath KM, Abraham I, et al. (2000) Increased amyloid precursor protein expression and serotonergic sprouting following excitotoxic lesion of the rat magnocellular nucleus basalis: neuroprotection by Ca(2+) antagonist nimodipine. Neuroscience 101: 101-114.
50. Cirrito JR, Disabato BM, Restivo JL, Verges DK, Goebel WD, et al. (2011) Serotonin signaling is associated with lower amyloid-beta levels and plaques in transgenic mice and humans. Proc Natl Acad Sci U S A 108: 14968-14973.
51. Hyman BT (2011) Amyloid-dependent and amyloid-independent stages of Alzheimer disease. Arch Neurol 68: 1062-1064.
52. He Y, Zheng MM, Ma Y, Han XJ, Ma XQ, et al. (2013) Soluble oligomers and fibrillar species of amyloid beta-peptide differentially affect cognitive functions and hippocampal inflammatory response. Biochem Biophys Res Commun 429: 125-130.
53. Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT (2011) Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med 1: a006189.
54. Fukushima T, Nakamura A, Iwakami N, Nakada Y, Hattori H, et al. (2011) T-817MA, a neuroprotective agent, attenuates the motor and cognitive impairments associated with neuronal degeneration in P301L tau transgenic mice. Biochem Biophys Res Commun 407: 730-734.
55. Van der Jeugd A, Hochgrafe K, Ahmed T, Decker JM, Sydow A, et al. (2012) Cognitive defects are reversible in inducible mice expressing pro-aggregant full-length human Tau. Acta Neuropathol 123: 787-805.
56. Hochgrafe K, Sydow A, Mandelkow EM (2013) Regulatable transgenic mouse models of Alzheimer Disease: Onset, Reversibility and Spreading of Tau pathology. FEBS J.
57. Cuadrado-Tejedor M, Hervias I, Ricobaraza A, Puerta E, Perez-Roldan JM, et al. (2011) Sildenafil restores cognitive function without affecting beta-amyloid burden in a mouse model of Alzheimer's disease. Br J Pharmacol 164: 2029-2041.
58. Orejana L, Barros-Minones L, Jordan J, Puerta E, Aguirre N (2012) Sildenafil ameliorates cognitive deficits and tau pathology in a senescence-accelerated mouse model. Neurobiol Aging 33: 625 e611-620.